DCF — BAPTIST HEALTH SYSTEM
Enterprise Value: $1.6B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.6B
Enterprise Value
$446.9M
PV of Cash Flows
$1.2B
PV of Terminal Value
$1.9B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.4B | $193.0M | 14.0% | $95.8M | $87.1M |
| Year 2 | $1.4B | $212.8M | 15.0% | $109.2M | $90.2M |
| Year 3 | $1.4B | $233.6M | 16.0% | $123.2M | $92.6M |
| Year 4 | $1.5B | $248.0M | 17.0% | $132.5M | $90.5M |
| Year 5 | $1.5B | $259.2M | 17.0% | $139.3M | $86.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $1.6B. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.3B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1372669278654225
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5